Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04953962
Title Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors CanBas Co. Ltd.

pancreatic cancer


CBP501 + Cisplatin + Nivolumab

Cisplatin + Nivolumab

CBP501 + Cisplatin

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.